The Oxford Nanopore EPI2ME platform aims to enable anyone to complete data analysis workflows, even without prior bioinformatics knowledge. To further support these goals and in collaboration with our tertiary analysis partners, we are providing integrated end-to-end solutions from sample to report for whole-genome sequencing applications. We are initially offering these integrated analysis solutions to support the research of rare and undiagnosed diseases and intend to expand our portfolio of end-to-end solutions in the future.
If you would like to be among the users to access these solutions, please fill out this form.